Stock Analysis

Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. If you are […]

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a pioneering clinical-stage biopharmaceutical company, has captured the attention of investors with its promising drug

If you are wondering whether CACI International is still good value after a strong run, looking at what you are

Theravance Biopharma, Inc. (NASDAQ: TBPH) presents a compelling opportunity for investors interested in the biotechnology sector. With a market capitalization

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, is at the forefront of developing biotherapeutics for cancer and autoimmune diseases.

Investors with an eye on the burgeoning field of cancer diagnostics may want to consider Personalis, Inc. (NASDAQ: PSNL), a

Talkspace, Inc. (NASDAQ: TALK), a trailblazer in virtual behavioral healthcare, offers investors a unique opportunity in the burgeoning digital health

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates a range of medical care facilities

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, particularly within the medical devices industry, offers a

Keros Therapeutics, Inc. (NASDAQ: KROS) is making waves in the biotechnology sector with its promising pipeline and recent analyst ratings